TLPH Q2 2023 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q2 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$253,000-55.6% YoY

Gross Profit

-$1M-513.4% margin

Operating Income

-$4M-1568.8% margin

Net Income

-$4M-1727.7% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$471,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$7M

Stockholders' Equity

$10M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$253,000	$570,000	-55.6%
Gross Profit	-$1M	-$306,000	-324.5%
Operating Income	-$4M	-$9M	+54.2%
Net Income	-$4M	$71M	-106.2%